Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP617667.RAC4RwczdUwgVZZEafRJL-s50Jvx8DBEUXj2Nc68f_Mtc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP617667.RAC4RwczdUwgVZZEafRJL-s50Jvx8DBEUXj2Nc68f_Mtc130_assertion type Assertion NP617667.RAC4RwczdUwgVZZEafRJL-s50Jvx8DBEUXj2Nc68f_Mtc130_head.
- NP617667.RAC4RwczdUwgVZZEafRJL-s50Jvx8DBEUXj2Nc68f_Mtc130_assertion wasGeneratedBy ECO_0000203 NP617667.RAC4RwczdUwgVZZEafRJL-s50Jvx8DBEUXj2Nc68f_Mtc130_provenance.
- NP617667.RAC4RwczdUwgVZZEafRJL-s50Jvx8DBEUXj2Nc68f_Mtc130_assertion wasDerivedFrom befree-2016 NP617667.RAC4RwczdUwgVZZEafRJL-s50Jvx8DBEUXj2Nc68f_Mtc130_provenance.
- NP617667.RAC4RwczdUwgVZZEafRJL-s50Jvx8DBEUXj2Nc68f_Mtc130_assertion SIO_000772 17599933 NP617667.RAC4RwczdUwgVZZEafRJL-s50Jvx8DBEUXj2Nc68f_Mtc130_provenance.
- NP617667.RAC4RwczdUwgVZZEafRJL-s50Jvx8DBEUXj2Nc68f_Mtc130_assertion evidence source_evidence_literature NP617667.RAC4RwczdUwgVZZEafRJL-s50Jvx8DBEUXj2Nc68f_Mtc130_provenance.
- NP617667.RAC4RwczdUwgVZZEafRJL-s50Jvx8DBEUXj2Nc68f_Mtc130_assertion description "[For example, the ERBB2 amplicon (17q21) in breast cancer is associated with poor patient prognosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP617667.RAC4RwczdUwgVZZEafRJL-s50Jvx8DBEUXj2Nc68f_Mtc130_provenance.